Profil
David Gray currently works at Vigil Neuroscience, Inc., as Chief Scientific Officer from 2023.
Dr. Gray also formerly worked at Pfizer Inc., as Senior Director-Neuroscience Biology, Inscopix, Inc., as Chief Scientific Officer, and Cerevel Therapeutics Holdings, Inc., as Vice President-Chemistry.
Dr. Gray received his doctorate degree from The Scripps Research Institute and undergraduate degree from the University of Minnesota.
Aktive Positionen von David Gray
| Unternehmen | Position | Beginn |
|---|---|---|
| VIGIL NEUROSCIENCE, INC. | Technik-/Wissenschafts-/F&E-Leiter | 27.02.2023 |
Ehemalige bekannte Positionen von David Gray
| Unternehmen | Position | Ende |
|---|---|---|
| CEREVEL THERAPEUTICS HOLDINGS, INC. | Corporate Officer/Principal | - |
| PFIZER INC. | Corporate Officer/Principal | - |
Inscopix, Inc.
Inscopix, Inc. BiotechnologyHealth Technology Develops and produces miniature integrated microscopes and related devices | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von David Gray
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Minnesota
University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inscopix, Inc.
Inscopix, Inc. BiotechnologyHealth Technology Develops and produces miniature integrated microscopes and related devices | Health Technology |
Vigil Neuroscience, Inc.
Vigil Neuroscience, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops therapeutics for neurodegenerative diseases | Health Technology |
Cerevel Therapeutics Holdings, Inc.
Cerevel Therapeutics Holdings, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops novel therapies for neurological and psychiatric disorders | Health Technology |
















